Feedback / Questions
Valcyte (valganciclovir) - Roche, Mitsubishi Tanabe
nanatinostat (VRx-3996) - Viracta Therap
https://www.prnewswire.com/news-releases/viracta-therapeutics-announces-presentation-of-updated-phase-2-data-at-ash-2020-and-productive-outcome-of-its-recent-end-of-phase-2-meeting-with-the-fda-301187296.html
Dec 7, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next